Genavent specializes in investments in genomics, life sciences and biotechnology.
Genavent, FCPR specializes in investments in genomics, life sciences and biotechnology and in companies with advanced technologies that provide access to new medicines, vaccines or agricultural products.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 24, 2006
Amphora Discovery
|
Series E | $4.37M | Biotechnology | — |
Jun 15, 2005
Amphora Discovery
|
Series D | $9.55M | Biotechnology | — |
Dec 5, 2002
Catalyst Bioscience
|
Series Unknown | $46M | Biotechnology | — |
Aug 16, 2000
E-Markets
|
Series B | $10M | Agriculture | — |
Genavent has had 3 exits. Genavent most notable exits include E-Markets , Amphora Discovery
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Sep 3, 2013 | E-Markets | M&A | Agriculture | Detail |
Jul 31, 2008 | Amphora Discovery | M&A | Biotechnology | Detail |
Apr 21, 2006 | Catalyst Bioscience | IPO | Biotechnology | Detail |